Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-18

Clinical Trial Update: Study of AC-201 in Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 trial of AC-201 in Type 2 diabetes mellitus has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AC-201

Snippet

Sponsor: TWi Biotechnology, Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2014-11-18